(Non-V600)BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

PURPOSE: Molecular diagnostic testing has become an integral part of the evaluation of patients with metastatic colorectal cancer (CRC). Expanded mutational testing, such as next-generation sequencing (NGS), often identifies mutations with unclear clinical or prognostic implications. One such exampl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Jones, Jeremy C., Renfro, Lindsay A., Al-Shamsi, Humaid O., Schrock, Alexa B., Rankin, Andrew, Zhang, Ben Y., Kasi, Pashtoon M., Voss, Jesse S., Leal, Alexis D., Sun, James, Ross, Jeffrey, Ali, Siraj M., Hubbard, Joleen M., Kipp, Benjamin R., McWilliams, Robert R., Kopetz, Scott, Wolff, Robert A., Grothey, Axel
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5549454/
https://ncbi.nlm.nih.gov/pubmed/28486044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.4394
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados